Fluke Biomedical OneQA Now Supports Patient Monitor Testing
Fluke Biomedical announced the OneQA test and workflow automation software now supports the top-selling ProSim 8 multifunction patient simulator. Fluke Biomedical OneQA is an industry-leading quality assurance software platform that helps hospitals, independent service organizations and OEM service teams increase the safety, efficiency, and accuracy of medical equipment testing and quality assurance workflows.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220712005328/en/
OneQA interoperability with ProSim 8 saves time and reduces error by automatically setting up the simulation to be sent to the monitor. (Graphic: Business Wire)
“OneQA interoperability with ProSim 8 saves time and reduces error by automatically setting up the simulation to be sent to the monitor,” explained Gerald Zion, global training manager for Fluke Biomedical. “The observed display and strip chart information that must be manually entered is automatically evaluated by OneQA using the pre-determined testing limits for the information that has been entered. This results in the objective pass/fail.”
Fluke Biomedical OneQA automates a selection of Fluke Biomedical tools which now includes the ProSim 8. OneQA can be used as a stand-alone workflow and documentation application or can be connected to a CMMS system.
“Our customers asked us to add patient monitor testing to the OneQA procedure library and its automated document workflows,” said Kiran Jagilinki, product manager for Fluke Biomedical OneQA. “Customers can now further standardize their testing workflows and benefit from a new consolidated PM report for patient monitor testing.”
For more information on Fluke Biomedical OneQA, visit: https://www.flukebiomedical.com/oneqa.
About Fluke Health Solutions
Fluke Health Solutions empowers our everyday heroes to focus only on protecting lives. Comprised of three industry leaders—Fluke Biomedical, LANDAUER, and RaySafe—Fluke Health Solutions leads the biomedical and radiation detection markets with innovative products and services that help keep customers, patients, and clients safe.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
For more information:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mary Kay Inc. Continues Its Support of Women’s Empowerment at the International Women’s Forum Cornerstone Conference in Chile12.8.2022 18:33:00 CEST | Press release
Mary Kay Inc. continues its support of women’s entrepreneurship, empowerment and thought leadership as a sponsor of the 2022 International Women’s Forum (IWF) Cornerstone Conference. Taking place on 17-18 May in Santiago, the Conference convened global decision makers who explored the most pressing challenges to progress on gender equality for the Latin American region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220812005257/en/ IWF Latinobarómetro MKI Latin American Women Democracy & Society from a Gender Perspective Research (Graphic: Mary Kay Inc.) For the first time ever, IWF commissioned groundbreaking research as part of its annual conference programming with funding by Mary Kay. Conducted by the Latinobarómetro founded by Marta Lagos, this research, titled “Latin American Women: Democracy & Society from a Gender Perspective,” is the first-ever analysis of a quarter of a century (1995-2020) of public opinion and at
Ipsen Completes Acquisition of Epizyme Expanding Its Portfolio in Oncology12.8.2022 17:35:00 CEST | Press release
Regulatory News: Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: IPSEY) today announced the closing of the definitive merger agreement under which Ipsen has acquired Epizyme, Inc. (Epizyme). Pursuant to the transaction, Ipsen acquires all outstanding shares of Epizyme for $1.45 per share plus a contingent value right (CVR) of $1.00 per share. Epizyme now operates as ‘an Ipsen company’ at deal close. As part of the transaction, Ipsen acquires Epizyme’s lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor, which was granted Accelerated Approval by the U.S. Food and Drug Administration (FDA) in 2020. It is currently indicated for adults with relapsed or refractory follicular lymphoma (FL) whose tumors are positive for an EZH2 mutation as detected by an FDA-approved test and who have received at least two prior systemic therapies, and for adult patients with relapsed or refractory follicular lymphom
Budweiser Celebrates 100 Days to The FIFA World Cup™ by Partnering with Messi, Neymar Jr. and Sterling to Drop Hundreds of Prizes For Fans Around the World12.8.2022 13:00:00 CEST | Press release
Tomorrow, Budweiser, an Anheuser-Busch InBev (AB InBev) global brand will “drop” prizes in select destinations in the lead up to the biggest global sporting event. As the Official Beer of the FIFA World Cup, Budweiser is giving fans the once-in-a-lifetime chance to experience the FIFA World Cup in person by dropping hundreds of red prize boxes in major cities that include signed memorabilia, a year’s supply of Budweiser, and the grand prize of a trip to the tournament. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220812005051/en/ Budweiser's QR code (Graphic: Business Wire) Beginning August 13, coordinates leading to prize boxes will be revealed to fans who scanned exclusive Budweiser QR codes. These exclusive QR codes were shared on Budweiser and athlete partner social accounts earlier this week, spurring curiosity and excitement from eager fans. QR codes appeared in locations commemorating Messi, Neymar Jr. and Sterling;
Q4 Inc. Announces Second Quarter 2022 Results12.8.2022 13:00:00 CEST | Press release
Q4 Inc. (TSX:QFOR) (“Q4” or the “Company”), a leading capital markets communications platform, today announced its financial results for the three and six months period ended June 30, 2022. All amounts are expressed in US dollars unless otherwise stated. “The second quarter results show our continued progress against our overall strategy and vision,” said Darrell Heaps, CEO of Q4. “We achieved double digit recurring revenue growth, driving product adoption with higher ARPA expansion growth, as our customers continued to renew subscriptions at record levels and increase their spend with Q4. Given the challenging macro environment, and with our peak investment period behind us, we are accelerating our path to profitability. With a focus on expanding our operating leverage, initiatives are underway to improve sales efficiency and utilize low cost geographies to drive down operating expenses. Combined with our gross margin expansion, these will bring forward our commitment to be cash and E
Zayed Sustainability Prize 2023 Demonstrates Global Reach and Impact with over 4,500 Submissions11.8.2022 16:48:00 CEST | Press release
Following a successful 4-month submissions phase, the Zayed Sustainability Prize, the UAE's pioneering global award for recognising excellence in sustainability, has officially closed entries for its 2023 awards cycle. Over 4,500 applications were received across the five Prize categories of Health, Food, Energy, Water and Global High Schools, from a record 152 countries, demonstrating the Prize’s growing global reach and impact. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220811005418/en/ The Zayed Sustainability Prize 2023 receives more than 4,500 submissions globally (Graphic: AETOSWire) The Zayed Sustainability Prize winners will be announced at the 2023 Zayed Sustainability Prize Awards Ceremony that will be held on January 16, 2023 as part of Abu Dhabi Sustainability Week. The Prize witnessed a 13% increase in submissions compared to last year from small and medium-sized enterprises (SMEs), nonprofit organisations a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom